The PEPPER panel discusses the use of artificial intelligence in diabetes management. PEPPER stands for Patient Empowerment through Predictive Personalised decision support. On the panel: Matthias Rolf, Clare Martin, @MReddyImperial@BRM1286#diabetes#t1d@PepperH2020
Kicking off the @PepperH2020 event with a panel discussion on “AI: The future of diabetes self-management” with experts from Oxford Brookes, Imperial College and Cellnovo. #T1D#diabetes@Pari_Avari@MReddyImperial Clare Martin, Matthias Rolf, @BRM1286
Cellnovo will take part in a panel on "AI: The Future of Diabetes Self-Management?" next week in London with @PepperH2020. Hope to see you there! Sign up: https://t.co/dHsGTlGQEr #AI#T1D#diabetes#GBDOC
Cellnovo will take part in a panel on "AI: The Future of Diabetes Self-Management?" next week in London with @PepperH2020. Hope to see you there! Sign up: https://t.co/dHsGTlGQEr #AI#T1D#diabetes#GBDOC
More than half of the tickets are sold out!! Get yours now to avoid disappointment https://t.co/Ii0oWmLyzk Join us for a lively evening where we talk AI, diabetes and medical technologies #type1#diabetes#gbdoc#T1D
Using real-time #data and an innovative #insulin delivery system, we partnered with @Cellnovo to create the world’s first connected mobile #diabetes management system. #health#digitalhealth https://t.co/CQF09GPa4S
Here's Youchaou presenting the Cellnovo GEN 3 System during our hands on training session @ATTDconf 2019! Great presentation and thank you all for your participation! #attd2019#cellnovoteam#Berlin#DT1
Cellnovo élargit sa base d’utilisateurs potentiels: Les cartouches d’insuline du système Gen3 sont désormais rechargeables, les diabétiques avec des besoins d’insuline plus élevés pourront désormais utiliser le système Cellnovo #medtech#diabete
https://t.co/UmXtjWLfjQ
Cellnovo expands its base of potential users: Its insulin cartridges are now refillable, enabling people with insulin needs exceeding the current cartridge capacity to use the Cellnovo System, including some people with type 2 diabetes #diabetes https://t.co/bnkrBmNAA7
#bourse#medtech@Cellnovo lance une nouvelle application mobile pour permettre aux patients d'accéder à leurs données de gestion du #diabète en temps réel sur leur smartphone personnel.
Lire le communiqué : https://t.co/QPvoQ3ILkF
Thanks for the informative interview @Medgadget and @Flexintl at #CES2019. Great to see the Cellnovo Diabetes Management Platform mentioned among innovative medical technologies featured by Flex. Check it out: https://t.co/93imjGTsLG #diabetes#medtech
#bourse#biotech@Cellnovo publie son chiffre d'affaires du quatrième trimestre et de l'ensemble de l'exercice 2018
Lire le communiqué : https://t.co/BcdJromhWy
Cellnovo announces its Q4 and Full Year 2018 Sales: Strong growth in Q4 sales, annual revenues more than doubled compared to 2017 https://t.co/MUSKgf03Aj